Phase 1 Trial for Patients With Advanced Hematologic Malignancies Undergoing Reduced Intensity Allogeneic HCT With a T-cell Depleted Graft With Infusion of Conventional T-cells and Regulatory T-cells
Arms / Cohorts
Experimental:Arm A2: Fully matched (8/8) related/unrelated donor transplantation
Accepting patients
Experimental:Arm A3: Fully (8/8) matched related/unrelated donor transplantation
Accepting patients
Experimental:Arm C2: 7/8 mismatched related/unrelated donor transplantation
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.